1. Møller MB, d'Amore F, Christensen BE; Danish Lymphoma Study Group. Testicular lymphoma: a population-based study of incidence, clinicopathological correlations and prognosis. Eur J Cancer. 1994; 30:1760–4.
Article
2. Chan JK, Quintanilla-Martinez L, Ferry JA. Extrannodal NK/T-cell lymphoma, nasal type. In : Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press;2017. p. 368–71.
3. Pileri SA, Weisenburger DD, Sng I, Nakamura S, Muller-Hermelink HK, Chan WC, et al. Peripheral T-cell lymphoma, NOS. In : Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press;2017. p. 403–6.
4. King RL, Goodlad JR, Calaminici M, Dotlic S, Montes-Moreno S, Oschlies I, et al. Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis. Virchows Arch. 2020; 476:647–65.
Article
5. Booman M, Douwes J, Glas AM, de Jong D, Schuuring E, Kluin PM. Primary testicular diffuse large B-cell lymphomas have activated B-cell-like subtype characteristics. J Pathol. 2006; 210:163–71.
Article
6. Cheah CY, Wirth A, Seymour JF. Primary testicular lymphoma. Blood. 2014; 123:486–93.
Article
7. Brunn A, Nagel I, Montesinos-Rongen M, Klapper W, Vater I, Paulus W, et al. Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYC(low)BCL2 (low) subgroup may underlie the inferior prognosis as compared to systemic diffuse large B cell lymphomas. Acta Neuropathol. 2013; 126:603–5.
Article
8. Fonseca R, Habermann TM, Colgan JP, O'Neill BP, White WL, Witzig TE, et al. Testicular lymphoma is associated with a high incidence of extranodal recurrence. Cancer. 2000; 88:154–61.
Article